Date Modified

2024-07-01

Period

6/months

Report Summary

• Trial commenced on 06.12.2023. • Patient recruitment started. • Treatment has been initiated in 36 cutaneous leishmaniasis patients who are being followed up. • Final sample size: 200

Attached file